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Conventional embryonic stem cells (ESCs) or
induced pluripotent stem cells (iPSCs) derived from
primates resemblemouse epiblast stem cells, raising
an intriguing question regarding whether the naive
pluripotent state resembling mouse embryonic
stem cells (mESCs) exists in primates and how to
capture it in vitro. Here we identified several specific
signaling modulators that are sufficient to generate
rhesus monkey fibroblast-derived iPSCs with the
features of naive pluripotency in terms of growth
properties, gene expression profiles, self-renewal
signaling, X-reactivation, and the potential to
generate cross-species chimeric embryos. Interest-
ingly, together with recent reports of naive human
pluripotent stem cells, our findings suggest several
conserved signaling pathways shared with rodents
and specific to primates, providing significant in-
sights for acquiring naive pluripotency from other
species. In addition, the derivation of rhesus monkey
naive iPSCs also provides a valuable cell source for
use in preclinical research and disease modeling.
INTRODUCTION
Studies in rodents have indicated that pluripotent stem cells
(PSCs) can be classified into two distinct and stable pluripotent
states: the naive and the primed pluripotent states (Nichols and
Smith, 2009). The naive state is represented by mouse embry-
onic stem cells (mESCs) derived from the inner cell mass (ICM)
of preimplantation mouse blastocyst embryos (Evans and Kauf-
man, 1981; Brook and Gardner, 1997), while the primed state
corresponds to mouse epiblast stem cells (mEpiSCs) that have
been established from mouse epiblasts postimplantation (Tesar
et al., 2007; Brons et al., 2007). Moreover, naive and primed
pluripotent stem cells possess different gene expression profiles
and different signaling pathways to support their self-renewal.488 Cell Stem Cell 15, 488–496, October 2, 2014 ª2014 Elsevier Inc.For instance, mESCs require LIF signaling or the combinatorial
inhibition of extracellular regulated protein kinases (ERK) and
glycogen synthase kinase-3 (GSK3), while mEpiSCs depend
on basic fibroblast growth factor (bFGF) and transforming
growth factor-b (TGF-b) signaling (Tesar et al., 2007; Ying
et al., 2008). In addition, female mESCs retain an active X chro-
mosome status, but female mEpiESCs are kept in X-inactivation
status (Nichols and Smith, 2009). Furthermore, while primed
PSCs form flattened colonies with a slow proliferation rate and
are refractory to single-cell passaging, naive PSCs grow rapidly
and can be propagated through single-cell passaging (Nichols
and Smith, 2009). Most importantly, in contrast to primed plurip-
otent stem cells, naive PSCs possess no marked lineage-
commitment bias in vitro and are capable of repopulating into
the ICM of early blastocysts with high-grade chimerism in vivo
(Bradley et al., 1984; Nichols and Smith, 2009), making naive
PSCs important for creating chimeric animal models and study-
ing mammalian gene function and early development.
Although the distinct naive and primed pluripotent states have
been well established in rodents, conventional primate PSCs,
such as human and monkey ESCs and induced pluripotent
stem cells (iPSCs), more closely resemble postimplantation
mouse EpiSCs in terms of gene expression profiles, signaling
pathways required for proliferation, and intolerance to single-
cell passaging (Thomson et al., 1995, 1998; Takahashi et al.,
2007; Yu et al., 2007; Liu et al., 2008). Therefore, whether and
how the naive pluripotent state in primates can be established
is an important question. Recent studies have reported the deri-
vation of naive human PSCs in vitro by the conversion of primed
PSCs or by direct reprogramming of somatic cells, such as the
ectopic expression of LRH-1 and RARg or using small molecules
(Smagghe et al., 2013; Li et al., 2009; Buecker et al., 2010; Hanna
et al., 2010;Wang et al., 2011). Nevertheless, the dependence on
transgene expression or the absence of the complete set of
rodent naive PSC characteristics implies that a stable naive
pluripotent state in primates has not yet been demonstrated.
Most recently, several reports have established distinct stable
exogene-independent human naive pluripotent states in vitro
(Gafni et al., 2013; Chan et al., 2013; Ware et al., 2014; Theunis-
sen et al., 2014). As the derivation of human naive PSCs
requires different signaling pathways from the mouse, it remains
Figure 1. Generation of Naive iPSCs from
Rhesus Monkey Fibroblasts
(A) Representative images of primed iPSCs in the
presence of 20%KSR+bFGF, 2i/hLIF, or 2i/hLIF +
bFGF, after staining for ALP or immunostaining for
OCT4 and TRA-1-81. Scale bars, 100 mm.
(B) Naive iPSCs were expanded under basal
conversion conditions with the tested signaling
modulators for 8 days after plating. Pluripotency
maintenance was measured by the proportion of
TBX3 and TRA-1-81 double-positive colonies
among total colonies. Negative control: 2i/LIF +
bFGF (n = 3wells). All values are mean ± SEM from
3-well replicates.
(C) Representative images of naive and primed
iPSCs after immunostaining for TRA-1-81 and
TBX3. Scale bars, 100 mm.
(D) Representative images of iPSCs under basal
conversion conditions with JNKi (SP600125) and
p38i (SB203580) after staining for ALP and im-
munostaining for OCT4 and TRA-1-81. Scale bars,
100 mm.
(E) Colony formation of naive iPSCs after single-
cell passaging. Top: morphology of naive iPSC
colonies at day 1 and day 4 after passaging.
Bottom: ALP staining and immunostaining for
TRA-1-81 at day 3. Scale bars, 100 mm.
(F) Naive iPSCs were expanded under optimized
conversion conditions (2i/LIF + bFGF + JNKi +
p38i) with signaling modulators ROCK inhibitor
(10 mM Y27632) and PKC inhibitor (5 mM GO¨6983)
for 5 days. Left: morphology of iPSCs under the
different conditions. Right: immunostaining for
TRA-1-81. Scale bars, 100 mm.
See also Figure S1.
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Rhesus Monkey Naive iPSCsintriguing whether and how authentic naive PSCs could be
generated from nonhuman primates in vitro.
In this work, we sought to establish the rhesus monkey naive
pluripotent state by screening a panel of pluripotency-related
signaling pathways. With these efforts, we identified a combina-
tion of specific signaling pathway modulators that enable the
reprogramming of rhesus monkey fibroblasts into the naive
pluripotent stem cells.
RESULTS
Generation of Rhesus Monkey Naive iPSCs
In our initial experiments, we first established rhesus monkey
primed iPSC lines by overexpressing OCT4 and KLF4 and
culturing cells in the presence of a small molecule combination
that has been reported to facilitate reprogramming with onlyCell Stem Cell 15, 488–496Oct4 overexpression in the mouse (Li
et al., 2011). Although the resulting
primed iPSC lines could be maintained
in human ESC medium with pluripotency
in vitro and in vivo (Figures S1A–S1E and
S1G, available online), they rapidly differ-
entiated and lost their pluripotency when
transferred into 2i/LIF conditions that
maintain naive pluripotency in mice (2i/
LIF) (Figure 1A), thus suggesting thatauthoritative conditions supporting rodent naive pluripotency is
not sufficient for establishing the naive pluripotent state in
monkey.
To convert the primed iPSCs to the naive state in the pres-
ence of 2i/LIF, we selected and tested several pathway modu-
lators reported to be essential for mouse or human pluripotency
(Xu et al., 2010). Interestingly, dome-shaped colonies morpho-
logically similar to mouse ESCs appeared only when bFGF, a
cytokine critical for human pluripotency, was added to the
2i/LIF conditions. Alkaline phosphatase (ALP) staining and
immunostaining of the pluripotency markers TRA-1-81 and
OCT4 showed that TRA-1-81-positive dome-shaped colonies
were retained in the presence of bFGF after 5 days of culture
in 2i/LIF conditions (Figure 1A). Interestingly, these cell colonies
also express TBX3 (data not shown), a typical marker gene
of naive pluripotency (Dunn et al., 2014; Niwa et al., 2009)., October 2, 2014 ª2014 Elsevier Inc. 489
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Rhesus Monkey Naive iPSCsThese results suggest that the addition of bFGF to 2i/LIF con-
ditions is essential for converting the primed iPSCs into the
naive state in monkey, despite that the conversion efficiency
was low (8%–10% of total colonies were TRA-1-81/TBX3
double-positive and dome-shaped) (Figures 1B and 1C). We
termed these converted TRA-1-81/TBX3 double-positive iPSCs
as naive iPSCs.
Conversion Condition Optimization for Rhesus Monkey
Naive iPSCs
To understand how bFGF worked to generate rhesus monkey
naive iPSCs, we next investigated the major pathway down-
stream of bFGF, the mitogen-activated protein kinase (MAPK)
signaling pathway. There are at least three clearly characterized
MAPK families in mammalian cells: classical MAPK (ERK),
C-Jun N-terminal kinase/stress-activated protein kinase (JNK/
MAPK), and p38 kinase (Zhang and Liu, 2002). To identify
which of these had a predominant role, we tested antagonists
specific for ERK, JNK, and p38 individually or in combination
under our conversion conditions. We found that of these
three inhibitors, PD0325901, an inhibitor of the classical
MAPK/ERK and an indispensable component of 2i/LIF condi-
tions, was essential for conversion and maintenance of TBX3/
TRA-1-81 double-positive dome-shaped colonies (data not
shown). Furthermore, two other molecules, SP600125 for
JNKi and SB203580 for p38i can each greatly improved the
conversion efficiency of naive PSCs in our conversion condi-
tions (Figures 1B and S1H). A combination of these two
inhibitors further enhanced the conversion efficiency to 75%
of the total colonies (Figures 1B–1D). Moreover, when these
colonies were picked and single-cell passaged, typical ALP-
positive, dome-shaped colonies appeared after 3 days of
culture on mouse embryonic fibroblast feeder cells. Further
identification by immunostaining indicated that these colonies
were TRA-1-81-positive, suggesting that they remained plurip-
otent (Figure 1E).
To optimize the conversion conditions, we also tested Y27632
(a ROCK inhibitor) and GO¨6983 (a PKC inhibitor), which are
beneficial for the survival of and maintaining human naive
ESCs/iPSCs (Gafni et al., 2013). However, we found that
these two compounds induced pronounced differentiation and
reduced TRA-1-81 expression in the colonies (Figure 1F),
implying different requirements on signaling regulation for estab-
lishing naive pluripotency in human and monkey.
Finally, using a combination of SP600125 and SB203580 in
the presence of bFGF and 2i/LIF, we successfully established
stable TRA-1-81/TBX3 double-positive dome-shaped naive
iPSCs at a high efficiency (10-fold higher than 2i/hLIF+bFGF
only) from primed iPSCs (Figure 1B). Notably, with this opti-
mized culture condition, we were able to reprogram rhesus
monkey fibroblasts into TRA-1-81-positive dome-shaped col-
onies directly by overexpression of OCT4, SOX2, and KLF4
(Figure S2A). We also employed our optimized culture condi-
tion to establish naive iPSCs using a nonviral integration
method based on episomal vectors as previously described
(Okita, et al., 2011) (Figure S1F, S2B, and S2C). Established
naive iPSCs could be single-cell passaged every 4–5 days by
using accutase and displayed high growth rates (Figures 1E
and 2A).490 Cell Stem Cell 15, 488–496, October 2, 2014 ª2014 Elsevier Inc.Pluripotency Characteristics of Rhesus Monkey Naive
iPSCs
We next aimed to address whether these naive iPSCs were
indeed pluripotent. RT-PCR analysis showed that naive iPSCs
expressed endogenous pluripotency marker genes, including
OCT4, SOX2, SALL4, and NANOG (Figures 2B and S2B). The
pluripotent characteristics of the naive iPSCs were further exam-
ined by immunostaining. Specifically, these cells stained positive
for pluripotency-specific surface markers, including TRA-1-60,
TRA-1-81, and SSEA-4, but not SSEA-1 (Figures 2C and S2C).
On the other hand, these cells had normal karyotypes (42, XY
for male and 42, XX for female) and maintained dome-shaped
morphology and ALP activity for over 8 months of single-cell
passaging (Figures 2D and S2D). Finally, to analyze the differen-
tiation potential of naive iPSCs, we tested their capacity to differ-
entiate into three germ layers. Naive iPSCs formed teratomas
with tissues of all three germ layers that were detected in vivo
4–5 weeks after injection into recipient mice (Figures 2E and
S2E). Thus, these results indicate that rhesus monkey naive
iPSCs possess pluripotent characteristics and differentiation
potential.
Rhesus Monkey Naive iPSCs Possess Properties
Different from Those of Primed iPSCs
To further investigate the differences between primed and naive
iPSCs, we focused on the distinct response patterns of primed
and naive iPSCs to different signaling stimuli or inhibitors (Greber
et al., 2010; Niwa et al., 2009; Vallier et al., 2009). We found that
the self-renewal of naive iPSCs depended on the LIF signaling,
similar to murine and human naive iPSCs. When exposed to a
JAK/ STAT3 inhibitor, naive iPSCs readily differentiated with
greatly reduced expression of TRA-1-81, while primed iPSCs
maintained their pluripotent properties (Figure 3A). Importantly,
as in human cells, the bFGF signaling was required for both rhe-
susmonkey primed and naive iPSC self-renewal. In the presence
of the FGFR inhibitor SU5402, few TRA-1-81-positive colonies
formed by either primed or naive iPSCs, suggesting an essential
role for this pathway in primate pluripotency regulation (Fig-
ure 3A). We also noticed that Ly294002, a typical phosphatidyli-
nositol 3-kinase (PI3K) inhibitor, could severely block the naive
conversion process in a concentration-dependent manner,
suggesting a critical role of FGF downstream PI3K signaling in
naive state establishment (Figures S3B and S3C). Interestingly,
the addition of a specific and selective TGF-b-RI inhibitor
SB431542 to the culture medium showed no effect on rhesus
monkey naive iPSCs but was devastating to primed iPSCs
self-renewal, indicating that, unlike for rhesus monkey primed
iPSCs and the reported human naive iPSCs (Gafni et al., 2013;
Theunissen et al., 2014), the TGF-b signaling was dispensable
for monkey naive iPSC self-renewal (Figures 3A and S3A).
We then analyzed the X chromosome activation states in
female naive iPSCs. Female naive iPSCs derived by our opti-
mized condition possessed an X chromosome reactivation state,
as indicated by the loss of H3K27me3 foci in the nuclei and
dramatic downregulation of XIST expression levels (Figures 3B
and 3C). In contrast, the female primed iPSCs maintain an
X chromosome inactivated state, with a clear presence of
H3K27me3 foci and high expression level of XIST as in somatic
cells (Figures 3B and 3C). Accordingly, these results suggest
Figure 2. Characterization of Rhesus
Monkey Naive iPSCs
(A) Colony reformation after single-cell passaging
of primed iPSCs and naive iPSCs. Pluripotency
maintenance was measured by the number of
TRA-1-81-positive colonies at day 5 after
passaging (n = 3 wells). p < 0.0001 (Student’s
t test). All values are mean ± SEM from 3-well
replicates.
(B) RT-PCR analysis of pluripotency gene ex-
pression in naive iPSCs. (N1, N2, N3: three inde-
pendently established naive iPSC lines; ES-7.5:
rhesus monkey ESC line).
(C) Representative images of naive iPSC colonies
after staining for ALP or immunostaining for OCT4,
SOX2, NANOG, TRA-1-60, TRA-1-81, SSEA-4, or
SSEA-1. Scale bars, 50 mm.
(D) Karyotype analysis showing the normal kar-
yotypes of naive iPSCs. The passage number
at which cells were collected for karyotyping is
indicated.
(E) In vivo teratoma differentiation of naive iPSCs.
The cells gave rise to well-differentiated mature
teratomas with cells from the all three germ line-
ages. Scale bars, 50 mm.
See also Figure S2.
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Rhesus Monkey Naive iPSCsthe conservation of an X-activation status in naive PSCs among
different species.
Next, we compared the global gene expression pattern be-
tween naive and primed iPSCs by RNA sequencing (RNA-seq)
analysis. Genome-wide gene expression clustering showed
that naive iPSCs clustered separately from primed iPSCs with
a distinct gene expression pattern (Figures 3D and 3E). Gene
ontology (GO) term analysis revealed changes of gene expres-
sion pattern related to major developmental signaling and
metabolism between naive and primed iPSCs (Figure S3D). Im-
portantly, compared with primed iPSCs, multiple naive state-Cell Stem Cell 15, 488–496related transcripts, such as PRDM14,
KLF5, ZFP42 (REX1), LIFR, TBX3, and
NANOG, were upregulated in naive iPSCs
(Figure 3F, 3G, and S3E). Meanwhile,
naive iPSCs also showed a decrease in
the expression of lineage-specific genes,
including HOXA2, MEIS1, and DLL1,
which were expressed at low but appre-
ciable levels in primed iPSCs (Figures 3F
and 3G). Collectively, these data indi-
cated that the gene expression pattern
of naive iPSCs was distinct from that of
primed iPSCs in rhesus monkey, which
is similar to previous studies in mice and
humans (Gafni et al., 2013; Chan et al.,
2013; Ware et al., 2014; Theunissen
et al., 2014).
Finally, to test the ability of rhesusmon-
key naive iPSCs in generating interspe-
cies chimeras in vivo, naive and primed
iPSCs were microinjected into 8-cell
stage embryos or embryonic day 3.5(E3.5) blastocysts of ICR mice and allowed to develop to the
E10–E11 developmental stages (Figure S4D). Whole-mount im-
munostaining of anti-human nuclei antibody (hNA), which can
specifically mark the nuclei of monkey cells (Figure S4A), was
used for detecting the presence of rhesus monkey iPSC-derived
cells in vivo. Notably, in contrast to the primed iPSCs, we were
able to obtain chimeric embryos with naive iPSCs (Figure S4D).
Particularly, three out of six chimeric embryos generated from
three naive iPSC lines showed a widespread integration of naive
iPSC-derived cells (Figures 4A and S4B). To further investigate
whether these naive iPSC-derived cells can contribute to the, October 2, 2014 ª2014 Elsevier Inc. 491
Figure 3. Differences between Rhesus Monkey Naive iPSCs and Primed iPSCs
(A) Naive iPSCs were expanded under optimized conversion conditions (top). Primed iPSCs were expanded in the hESCs medium (bottom). The signaling
modulators tested were as follows: 1 mM JAK inhibitor, 10 mM SB431542 (TGF-bR inhibitor), 2 ng/ml TGF-b1, and 2 mM SU5402 (FGFR inhibitor). Pluripotency
maintenance was measured by the fold change in the proportion of TRA-1-81-positive dome-shaped colonies relative to the controls (optimized conversion
conditions for naive iPSCs) or TRA-1-81-positive colonies relative to the controls (hESCs medium for primed iPSCs). The different color columns represent
individual cell lines (n = 3 different wells). N1, N2, N3: three naive iPSC lines; P1, P2, P3: three primed iPSC lines. All values aremean ± SEM from 3-well replicates.
(B) X chromosome activation state is shown by representative confocal images of naive and primed iPS colonies after immunostaining for H3K27me3 (FN-1 and
FN-2: female naive iPSC lines; FP-1 and FP-2: female primed iPSC lines). Scale bars, 50 mm.
(C) qPCR and RT-PCR analysis of XIST expression (FN-1 and FN-2: female naive iPSC lines; FP-1 and FP-2: female primed iPSC lines; FF-1 and FF-2: female
fibroblast cell lines; N1: a male naive iPSC line; MF: a male fibroblast cell line). The results of RT-PCR are shown relative to the average expression level of XIST in
primed iPSCs (Female #1 and #2: two female cell sources; N: naive; P: primed; F: fibroblasts). All values are mean ± SEM from three independent experiments.
(D) The heatmap shows the Jensen-Shannon divergences of whole genomic expression profile between naive iPSCs (N1, N2, FN-1, and FN-2), primed iPSCs
(P1, P2), and fibroblasts (F1, F2). The divergence between a cell line and itself is zero. Hence, all the points on the main diagonal are colored white.
(legend continued on next page)
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Rhesus Monkey Naive iPSCsembryonic development of chimeric embryos, we analyzed the
distribution of naive iPSC-derived cells in chimeric embryos at
the E16 developmental stage. Two E16 chimeric embryos from
two independent naive cell lines were further analyzed.We found
that naive iPSC-derived cells integrated into many tissues and
organs of recipient mice, such as the intestine, liver, heart, and
brain. The expression of pluripotency marker including OCT4
and NANOG cannot be detected in the hNA+ cells in the chimeric
embryos (Figure S4C), suggesting the loss of pluripotency in the
naive iPSC-derived cells. Interestingly, we also observed a high-
grade integration of the naive iPSC-derived cells in the heart
region (Figure 4B). Moreover, a cardiac-specific marker GATA4
(detected by staining with a GATA4 antibody, which reacted
with both human and mouse GATA4) was expressed in most of
the hNA+ cells in the heart at this stage (Figure 4B) (Kuo et al.,
1997), implying that these naive iPSC-derived cells may further
differentiate toward the cardiac fate when integrating into the
developing heart. Together, these data suggest that rhesus
monkey naive iPSC-derived cells could generate interspecies
chimeric embryo and repopulate into the mouse early embryos
with further differentiation.
DISCUSSION
In this study, we provide evidence that rhesus monkey naive
iPSCs can be successfully generated by conversion from primed
iPSCs or by transcription factor-driven reprogramming of fibro-
blasts with a simple combination of cytokines and small-mole-
cule inhibitors. Moreover, this conversion condition also allows
long-term stable maintenance of the self-renewal circuitry of
naive iPSCs. Importantly, our findings suggest that naive plurip-
otency, with interspecies chimeric capacity into mouse em-
bryos, can be derived in nonhuman primates (Figure 4A, 4B,
S4B, and S4D). Furthermore, our discovery of monkey naive
iPSCs confirms that the naive and primed pluripotent states
are not only restricted to murine and human cells, but may be
conserved across species.
The generated rhesus monkey naive iPSCs possess a number
of cellular characteristics that distinguish them from primed
iPSCs and conventional primate ESCs. Rhesus monkey naive
iPSCs are amenable to single-cell passaging and can be propa-
gated for long periods with stable dome-shaped morphology
and normal karyotypes. These cells respond to LIF and MAPK-
independent bFGF signaling to self-renew with hallmarks of
pluripotency. The lack of H3K27me3 nuclear foci and downregu-
lation of XIST transcription indicated a pre-X inactivation state
of naive iPSCs. Additionally, the monkey naive iPSCs estab-
lished in our study also share an expression signature with
both murine and human naive pluripotent stem cells. For
instance, we observed the upregulation of naive state-related
genes, including NANOG and PRDM14, which serve to safe-(E) Clustering was performed on whole genomic expression profile (RNA-seq)
clustering.
(F) Transcriptional profile of typical pluripotency and lineage-specific marker gene
are shown by the Z score of the FPKMs of all samples for each gene.
(G) Quantitative PCR validation of typical pluripotency and lineage-specific marke
three independent experiments. p < 0.0001 (Student’s t test). All values are mea
See also Figure S3.
Ceguard the murine naive pluripotent state and repress lineage
commitment through the dual regulation of signaling pathways
and intracellular epigenetics (Silva et al., 2009; Yamaji et al.,
2013; Grabole et al., 2013). This finding is consistent with a
decrease in the expression of lineage-specific genes, such as
DLL1 andMEIS1 (van Es et al., 2012; Hisa et al., 2004), indicating
a more immature state of rhesus monkey naive iPSCs (Fig-
ure 3G). Hence, the entirely distinct phenotypes of the two
pluripotent states in monkey may provide an excellent model
system to investigate the mechanism of the pluripotency
network regulation in primates.
Another key finding in our study is thatmonkey naive iPSCs are
capable of generating cross-species chimeras when injected
into mouse embryos. Although this assay has been used to eval-
uate human naive PSCs, whether these cells lose their pluripo-
tent gene expression and can further differentiate and contribute
to tissues in vivo remains unclear (Gafni et al., 2013; Theunissen
et al., 2014). Here, we first used whole-mount staining, whole
embryo slicing, and imaging to obtain an overview of the distri-
bution of rhesusmonkey naive iPSC-derived cells in the chimeric
monkey-mouse embryos. The costaining of anti-human nuclei
antibody with tissue-specific markers and the absence of plurip-
otent-specific markers on the whole embryo-sliced specimen
further illustrated that naive iPSC-derived cells in the chimeric
embryos may further differentiate and contribute to embryo
development. Accordingly, whole embryo analysis may serve
an alternative strategy to provide more rigorous evidence of
naive pluripotency.
Our findings also indicate the evolutionary conservation and
variation in the conditions for achieving the naive pluripotent
state of mouse, monkey, and human cells. First, we found that
LIF/STAT3 signaling supports the naive state not only in themon-
key, but also in the other two species, suggesting a fundamental
effect of LIF/STAT3 signaling in establishing the naive pluripo-
tency network. Second, the antagonism of three central compo-
nents of MAPK, ERK, JNK, and p38 (Zhang and Liu, 2002) is
important for achieving the naive pluripotent state in these spe-
cies. Third and intriguingly, similar to human naive PSCs, the
rhesus monkey naive iPSCs rely on bFGF signaling to sustain
self-renewal. This finding is consistent with recent reports that
indicated the importance and indispensability of bFGF signaling
for human cells to acquire the naive pluripotent state (Gafni et al.,
2013; Chan et al., 2013; Ware et al., 2014), indicating that bFGF
signaling plays a pivotal role inmaintaining the naive state of both
human and monkey cells. In contrast, bFGF signaling has a
negative effect on the maintenance of the naive pluripotency in
mouse; this could be due to the distinct genetic background of
different species, as implied by the previous report (Hanna
et al., 2010). As MAPKs downstream of bFGF need to be
suppressed in primate naive PSCs, other signaling pathways
downstream of bFGF, such as PI3K, may exert positive effectsof primed (P1, P2) and naive iPSCs (N1, N2, FN-1, FN-2) using hierarchical
expression in naive (N1, N2, FN-1, FN-2) and primed (P1, P2) iPSCs. The results
r gene expression in naive and primed iPSCs. All values are the mean ± SD from
n ± SEM from three independent experiments.
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Figure 4. Chimeric Potential of Rhesus
Monkey Naive iPSCs and Primed iPSCs
(A) Representative images showing integration
of naive iPSCs into different locations in the
whole body of an E10.5 mouse embryo after
whole-mount immunostaining with an anti-human
nuclei antibody and confocal analysis. DAPI was
used for counterstaining. Scale bars, 150 mm.
The second and third columns show a
magnified image focusing on the head region
(yellow square) where the iPSC-derived cells
(green) are noted (z stack interval 10 mm; 7 focal
planes total). The fourth and fifth columns show a
zoomed in image focusing on the neck region
(yellow square) where the iPSC-derived cells
(green) are pointed out (z stack interval 10 mm;
7 focal planes total). Scale bars, 150 mm. Obvious
integration was not detected in the control
primed iPSC-injected mouse embryo (lower
panels). z stack interval 10 mm; 7 focal planes
total.
(B) Representative whole-embryo confocal im-
ages showing proper differentiation of monkey
naive iPSC-derived cells in the E16 chimeric
embryo. The whole embryo was embedded,
frozen, and sliced (10 mm thick), then cos-
tained with an anti-human nuclei antibody and
GATA4. Scale bars, 1.2 mm. Magnified images
focusing on the heart region where the naive
iPSC-derived cells (green) are integrated are
shown below. Bottom: left, three panels of
magnified in images of the heart region (scale
bars, 600 mm); right, three panels of magnified
images focusing on the indicated area (yellow
square) in the left panels (scale bars, 300 mm).
Further magnified images focusing on the
yellow arrowhead pointed area were shown as
indicated (top: merged panels; middle: hNA
staining; bottom: GATA4 staining). Scale bars,
100 mm. An E16 embryo with primed iPSC-
injected and noninjected embryos served as a
negative controls, following the same embed-
ding, slicing, and staining procedure on naive
iPSC-injected embryos.
See also Figure S4.
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Rhesus Monkey Naive iPSCson the naive pluripotency in primates (Figures S3B and S3C). In
addition, during the conversion process, we noticed a
remarkable similarity between the monkey and mouse naive
pluripotency in their independence of TGF-b signaling, which is
prominent in refractory and nonpermissive mouse and rat
strains (Hassani et al., 2012, 2014). In contrast, the previously re-
ported human naive PSCs depend on the presence of TGF-b
signaling (Gafni et al., 2013; Theunissen et al., 2014). The
opposite roles of TGF-b signaling in pluripotency regulation of
rhesus monkey and human also raise a further question of
whether TGF-b-signaling independent naive PSCs can be gener-
ated in humans.
Overall, the generation of rhesus monkey naive iPSCs indi-
cates that the two different pluripotent states (naive and primed)494 Cell Stem Cell 15, 488–496, October 2, 2014 ª2014 Elsevier Inc.are conserved across species. Most importantly, the discoveries
of similarities and differences among mouse, monkey, and hu-
man species in deriving naive pluripotent stem cells may aid in
unraveling the mystery of the naive pluripotency and may be
useful for obtaining authentic naive PSCs in other species. On
the other hand, the derivation of rhesus monkey naive iPSCs
also provides a valuable cell source for applications in preclinical
research and disease modeling.EXPERIMENTAL PROCEDURES
Generation of Rhesus Monkey Naive iPSCs
The adult rhesusmacaques (Macacamulatta, #9, #2, #11, and #12) used in this
study were housed in individual cages. All animal procedures were approved
Cell Stem Cell
Rhesus Monkey Naive iPSCsby the Laboratory Animal Center of the Chinese Academy of Military Medical
Science, and the use of rhesus macaque somatic cells was licensed by Peking
University Institutional Review Board. Fibroblasts were isolated from the ear
edge of rhesus monkeys and infected with retroviral vectors containing
reprogramming factors OCT4 and KLF4. Medium supplemented with the
small molecules was changed every 2 days. Primed iPSC colonies were
selected on approximately days 25–35 after viral transduction and expanded
in human ESC medium (D/F12 + 20% knockout serum replacements
[KSR] + 4 ng/ml bFGF). For naive state conversion, primed iPSC colonies
were dissociated by accutase and reseeded on feeder cells. The optimized
conversion medium with 4 ng/ml bFGF, 10 ng/ml human LIF, CHIR99021
(3 mM) and PD0325901 (0.5 mM), and SP600125 (10 mM) and SB203580
(10 mM) was changed daily. At approximately days 7–10, dome-shaped col-
onies were selected and then transferred onto fresh feeder cells for further
analysis of pluripotency and differentiation characteristics (see Supplemental
Experimental Procedures).
Mouse Embryo Micromanipulation, Whole-Mount Staining, and
Imaging
For naive and primed iPSC injection, cells were trypsinized and microinjected
into 8-cell stage embryos or E3.5 blastocysts of ICR diploid mouse embryo
(6–10 cells per embryo). Approximately 15 injected embryos were transferred
to each uterine horn of pseudopregnant females 2.5 days postcoitum.
Embryos were dissected at E10–E11 developmental stages for whole-mount
staining with anti-human nuclei antibody (clone 235-1, 1:200, Millipore) under
the whole-mount staining procedure from Abcam. For whole-embryo sliced
specimen imaging, embryos were dissected at the E16 developmental stages,
followed by embedding, freezing, and slicing (10 mm thick slices), then costain-
ing with anti-human nuclei antibody and GATA4 (1:200, Santa Cruz Biotech-
nology) or OCT4 (1:200, Abcam) and NANOG (1:200, R&D Systems). For
confocal analysis, mounted embryos and sliced specimens were imaged by
UltraVIEW VoX systems (PerkinElmer), Andor’s Revolution WD spinning disk
confocal microscopy system (Andor), or ImageXpress Micro High Content
Screening System (MolDev).
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